Cargando…

Immunoreactivity of Pluripotent Markers SSEA-5 and L1CAM in Human Tumors, Teratomas, and Induced Pluripotent Stem Cells

Pluripotent stem cell markers can be useful for diagnostic evaluation of human tumors. The novel pluripotent marker stage-specific embryonic antigen-5 (SSEA-5) is expressed in undifferentiated human induced pluripotent cells (iPSCs), but little is known about SSEA-5 expression in other primitive tis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassidy, Linda, Choi, Meerim, Meyer, Jason, Chang, Rui, Seigel, Gail M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437354/ https://www.ncbi.nlm.nih.gov/pubmed/26317026 http://dx.doi.org/10.1155/2013/960862

Ejemplares similares

Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces
por: Venable, Alison, et al.
Publicado: (2005)

Murine pluripotent stem cells that escape differentiation inside teratomas maintain pluripotency
por: Pei, Yangli, et al.
Publicado: (2018)

Cisplatin induces differentiation in teratomas derived from pluripotent stem cells
por: Kurata, Atsushi, et al.
Publicado: (2021)

Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays
por: Bouma, Marga J., et al.
Publicado: (2017)

Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells
por: Matsu-ura, Toru, et al.
Publicado: (2016)

Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem Cell-Derived Teratomas
por: Pappas, Matthew P., et al.
Publicado: (2022)

In vivo reprogrammed pluripotent stem cells from teratomas share analogous properties with their in vitro counterparts
por: Choi, Hyun Woo, et al.
Publicado: (2015)

Pluripotency of induced pluripotent stem cells
por: Kang, Lan, et al.
Publicado: (2012)

Pluripotency of Induced Pluripotent Stem Cells
por: Feng, Chunjing, et al.
Publicado: (2013)

Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders
por: Bedel, Aurelie, et al.
Publicado: (2016)

Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity
por: Cho, Seung-Ju, et al.
Publicado: (2015)

Prognostic Analysis of Human Pluripotent Stem Cells Based on Their Morphological Portrait and Expression of Pluripotent Markers
por: Krasnova, Olga A., et al.
Publicado: (2022)

Conditionally replicating adenovirus prevents pluripotent stem cell–derived teratoma by specifically eliminating undifferentiated cells
por: Mitsui, Kaoru, et al.
Publicado: (2015)

Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas
por: Kamada, Mizuna, et al.
Publicado: (2015)

Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas
por: Riegler, Johannes, et al.
Publicado: (2016)

TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas
por: Avior, Yishai, et al.
Publicado: (2015)

Photodynamic Approach for Teratoma-Free Pluripotent Stem Cell Therapy Using CDy1 and Visible Light
por: Cho, Seung-Ju, et al.
Publicado: (2016)

Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells
por: Benabdallah, Basma, et al.
Publicado: (2019)

The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation
por: Lezmi, Elyad, et al.
Publicado: (2020)

Lysine-specific demethylase 1 inhibitors prevent teratoma development from human induced pluripotent stem cells
por: Osada, Naoki, et al.
Publicado: (2018)

Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis
por: Kim, Aeyung, et al.
Publicado: (2020)

Characterization of Induced Pluripotent Stem Cell Microvesicle Genesis, Morphology and Pluripotent Content
por: Zhou, Jing, et al.
Publicado: (2016)

Development of Fluorescently Labeled SSEA-3, SSEA-4, and Globo-H Glycosphingolipids for Elucidating Molecular Interactions in the Cell Membrane
por: Asano, Sachi, et al.
Publicado: (2019)

Induced pluripotent stem cells are induced pluripotent stem cell-like cells
por: Song, Liting, et al.
Publicado: (2015)

Standardization of the Teratoma Assay for Analysis of Pluripotency of Human ES Cells and Biosafety of Their Differentiated Progeny
por: Gropp, Michal, et al.
Publicado: (2012)

Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
por: Galat, Vasiliy, et al.
Publicado: (2016)

In vitro expanded skeletal myogenic progenitors from pluripotent stem cell-derived teratomas have high engraftment capacity
por: Xie, Ning, et al.
Publicado: (2021)

Using Advanced Cell Culture Techniques to Differentiate Pluripotent Stem Cells and Recreate Tissue Structures Representative of Teratoma Xenografts
por: Smith, L. A., et al.
Publicado: (2021)

An Ethanol Extract of Coptidis rhizoma Induces Apoptotic Cell Death in Induced Pluripotent Stem Cells and Suppresses Teratoma Formation
por: Kim, Aeyung, et al.
Publicado: (2023)

Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma
por: Davidson, Ben, et al.
Publicado: (2020)

Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells
por: Tang, Shin Yi, et al.
Publicado: (2021)

The pluripotent stem cell-specific transcript ESRG is dispensable for human pluripotency
por: Takahashi, Kazutoshi, et al.
Publicado: (2021)

DNA Repair in Human Pluripotent Stem Cells Is Distinct from That in Non-Pluripotent Human Cells
por: Luo, Li Z., et al.
Publicado: (2012)

An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model
por: Mensah, Afua, et al.
Publicado: (2007)

The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays
por: Salvatori, Daniela C.F., et al.
Publicado: (2018)

Monoclonal antibody K312-based depletion of pluripotent cells from differentiated stem cell progeny prevents teratoma formation
por: Park, Jongjin, et al.
Publicado: (2022)

Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods—A Systematic Review
por: Montilla-Rojo, Joaquin, et al.
Publicado: (2023)

Human Induced Pluripotent Stem Cells Develop Teratoma More Efficiently and Faster Than Human Embryonic Stem Cells Regardless the Site of Injection
por: Gutierrez-Aranda, Ivan, et al.
Publicado: (2010)

Retrotransposons in pluripotent stem cells
por: Wang, Jingwen, et al.
Publicado: (2020)

Circulating SSEA-1(+) stem cell-mediated tissue repair in allergic airway inflammation
por: Chiu, Chiao-Juno, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4ajdl5qoam9cren6v55rfahao